Expansion of the phenotypic and molecular spectrum of CWF19L1-related disorder.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
05 2023
Historique:
revised: 28 11 2022
received: 29 10 2022
accepted: 29 11 2022
medline: 4 4 2023
pubmed: 2 12 2022
entrez: 1 12 2022
Statut: ppublish

Résumé

Pathogenic variants in CWF19L1 lead to a rare autosomal recessive form of hereditary ataxia with only seven cases reported to date. Here, we describe four additional unrelated patients with biallelic variants in CWF19L1 (age range: 6-22 years) and provide a comprehensive review of the literature. The clinical spectrum was broad, including mild to profound global developmental delay; global or motor regression in infancy or adolescence; childhood-onset ataxia and cerebellar atrophy; and early-onset epilepsy. Since only two previously reported patients were adults, our cohort expands our understanding of the evolution of symptoms from childhood into early adulthood. Taken together, we describe that CWF19L1-related disorder presents with developmental and epileptic encephalopathy with treatment-resistant seizures and intellectual disability in childhood followed by progressive ataxia and other extrapyramidal movement disorders in adolescence.

Identifiants

pubmed: 36453471
doi: 10.1111/cge.14275
doi:

Substances chimiques

CWF19L1 protein, human 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

566-573

Informations de copyright

© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Références

Beaudin M, Matilla-Duenas A, Soong BW, et al. The classification of autosomal recessive cerebellar ataxias: a consensus statement from the society for research on the cerebellum and ataxias task force. Cerebellum. 2019;18(6):1098-1125.
Burns R, Majczenko K, Xu J, et al. Homozygous splice mutation in CWF19L1 in a Turkish family with recessive ataxia syndrome. Neurology. 2014;83(23):2175-2182.
Algahtani H, Shirah B, Almatrafi S, Al-Qahtani MH, Abdulkareem AA, Naseer MI. A novel variant in CWF19L1 gene in a family with late-onset autosomal recessive cerebellar ataxia 17. Neurol Res. 2021;43(2):141-147.
Evers C, Kaufmann L, Seitz A, et al. Exome sequencing reveals a novel CWF19L1 mutation associated with intellectual disability and cerebellar atrophy. Am J Med Genet A. 2016;170(6):1502-1509.
Nguyen M, Boesten I, Hellebrekers DM, et al. Pathogenic CWF19L1 variants as a novel cause of autosomal recessive cerebellar ataxia and atrophy. Eur J Human Genet EJHG. 2016;24(4):619-622.
Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36(10):928-930.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424.
Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434-443.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521.
Scheffer IE, Liao J. Deciphering the concepts behind “epileptic encephalopathy” and “developmental and epileptic encephalopathy”. Eur J Paediatr Neurol. 2020;24:11-14.

Auteurs

Carolina Alvarez (C)

Department for genetics and personalized medicine, Danish Epilepsy Centre, Dianalund, Denmark.
Department of Pediatric Neurology, Avanced Epilepsy Center, Clínica Las Condes, Santiago, Chile.

Mona Grimmel (M)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Darius Ebrahimi-Fakhari (D)

Movement Disorders Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Victoria G Paul (VG)

Institute of Human Genetics, University of Münster, Münster, Germany.

Natalie Deininger (N)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Angelika Riess (A)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
Centre for Rare Diseases, University of Tuebingen, Tuebingen, Germany.

Tobias Haack (T)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
Centre for Rare Diseases, University of Tuebingen, Tuebingen, Germany.

Elena Gardella (E)

Department for genetics and personalized medicine, Danish Epilepsy Centre, Dianalund, Denmark.
Department of Clinical Neurophysiology, Danish Epilepsy Centre, Dianalund, Denmark.

Rikke S Møller (RS)

Department for genetics and personalized medicine, Danish Epilepsy Centre, Dianalund, Denmark.
Department Regional Health Research, University of Southern Denmark, Odense, Denmark.

Allan Bayat (A)

Department for genetics and personalized medicine, Danish Epilepsy Centre, Dianalund, Denmark.
Department Regional Health Research, University of Southern Denmark, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH